Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

In vitro coagulation triggers anti-Aspergillus fumigatus neutrophil response.

Fréalle E, Gosset P, Leroy S, Delattre C, Wacrenier A, Zenzmaier C, Zawadzki C, Aliouat EM, Perkhofer S.

Future Microbiol. 2018 May;13:659-669. doi: 10.2217/fmb-2017-0190. Epub 2018 May 23.

PMID:
29790796
2.

Promoting gender in medical and allied health professions education: Influence on students' gender awareness.

Siller H, Komlenac N, Fink H, Perkhofer S, Hochleitner M.

Health Care Women Int. 2017 Nov 2:1-17. doi: 10.1080/07399332.2017.1395881. [Epub ahead of print]

PMID:
29095120
3.

Identification of von Willebrand disease type 1 in a patient with Ehlers-Danlos syndrome classic type.

Ott HW, Perkhofer S, Coucke PJ, de Paepe A, Spannagl M.

Haemophilia. 2016 Jul;22(4):e309-11. doi: 10.1111/hae.12931. Epub 2016 Jun 13. No abstract available.

PMID:
27292226
4.

Comparison of different blood compartments for the detection of circulating DNA using a rat model of Pneumocystis pneumonia.

Fréalle E, Gantois N, Aliouat-Denis CM, Leroy S, Zawadzki C, Perkhofer S, Aliouat EM, Dei-Cas E.

Med Mycol. 2015 Sep;53(7):754-9. doi: 10.1093/mmy/myv050. Epub 2015 Jul 10.

PMID:
26162469
5.

Differential gene expression in Aspergillus fumigatus induced by human platelets in vitro.

Perkhofer S, Zenzmaier C, Frealle E, Blatzer M, Hackl H, Sartori B, Lass-Flörl C.

Int J Med Microbiol. 2015 May;305(3):327-38. doi: 10.1016/j.ijmm.2015.01.002. Epub 2015 Jan 17.

6.

Interference of mobile phones and digitally enhanced cordless telecommunications mobile phones in renal scintigraphy.

Stegmayr A, Fessl B, Hörtnagl R, Marcadella M, Perkhofer S.

Clin Nucl Med. 2013 Aug;38(8):597-603. doi: 10.1097/RLU.0b013e31828da340.

PMID:
23603594
7.

Aspergillosis: new insights into disease, diagnostic and treatment.

Perkhofer S.

Curr Pharm Des. 2013;19(20):3543-4. No abstract available.

PMID:
23278543
8.

Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity.

Schmidt S, Tramsen L, Perkhofer S, Lass-Flörl C, Hanisch M, Röger F, Klingebiel T, Koehl U, Lehrnbecher T.

Immunobiology. 2013 Jul;218(7):939-44. doi: 10.1016/j.imbio.2012.10.013. Epub 2012 Nov 2.

PMID:
23201314
9.

Interaction of platelets and anidulafungin against Aspergillus fumigatus.

Perkhofer S, Striessnig B, Sartori B, Hausott B, Ott HW, Lass-Flörl C.

Antimicrob Agents Chemother. 2013 Jan;57(1):626-8. doi: 10.1128/AAC.01534-12. Epub 2012 Oct 31.

10.

Microbial challenge tests on nonradioactive TiO2-based 68Ge/68Ga generator columns.

Petrik M, Schuessele A, Perkhofer S, Lass-Flörl C, Becker D, Decristoforo C.

Nucl Med Commun. 2012 Aug;33(8):819-23. doi: 10.1097/MNM.0b013e3283543323.

PMID:
22546876
11.

Characterization of the cellular immune responses to Rhizopus oryzae with potential impact on immunotherapeutic strategies in hematopoietic stem cell transplantation.

Schmidt S, Tramsen L, Perkhofer S, Lass-Flörl C, Röger F, Schubert R, Lehrnbecher T.

J Infect Dis. 2012 Jul 1;206(1):135-9. doi: 10.1093/infdis/jis308. Epub 2012 Apr 23.

PMID:
22529315
12.

Austrian clinical practice with anidulafungin in 2008: a multicenter survey.

Perkhofer S, Hell M, Gustorff B, Von Goedecke A, Illievich U, Kratzer C, Moosbauer W, Wimmer P, Zerlauth U, Nachbaur K, Vogel W, Bellmann R, Schwameis F, Lass-Flörl C.

J Chemother. 2011 Oct;23(5):285-9.

PMID:
22005061
13.

Inhibition of fibroblast growth factor receptor 1 endocytosis promotes axonal branching of adult sensory neurons.

Hausott B, Rietzler A, Vallant N, Auer M, Haller I, Perkhofer S, Klimaschewski L.

Neuroscience. 2011 Aug 11;188:13-22. doi: 10.1016/j.neuroscience.2011.04.064. Epub 2011 May 7.

PMID:
21575685
14.

In Vitro Susceptibility Testing in Fungi: What is its Role in Clinical Practice?

Perkhofer S, Mrazek C, Hartl L, Lass-Flörl C.

Curr Infect Dis Rep. 2010 Nov;12(6):401-8. doi: 10.1007/s11908-010-0134-z.

PMID:
21308547
15.

The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients.

Perkhofer S, Lass-Flörl C, Hell M, Russ G, Krause R, Hönigl M, Geltner C, Auberger J, Gastl G, Mitterbauer M, Willinger B, Knöbl P, Resch G, Waldner R, Makrai A, Hartmann G, Girschikofsky M, Greil R.

Int J Antimicrob Agents. 2010 Dec;36(6):531-6. doi: 10.1016/j.ijantimicag.2010.08.010. Epub 2010 Oct 13.

PMID:
20947312
16.

Platelets enhance activity of antimycotic substances against non-Aspergillus fumigatus Aspergillus species in vitro.

Perkhofer S, Trappl K, Striessnig B, Nussbaumer W, Lass-Flörl C.

Med Mycol. 2011 Feb;49(2):157-66. doi: 10.3109/13693786.2010.510150. Epub 2010 Aug 26.

PMID:
20795763
17.

Comparative functional analysis of the OCH1 mannosyltransferase families in Aspergillus fumigatus and Saccharomyces cerevisiae.

Lambou K, Perkhofer S, Fontaine T, Latge JP.

Yeast. 2010 Aug;27(8):625-36. doi: 10.1002/yea.1798.

18.

Potential synergistic activity of antimycotic substances in combination with human platelets against Aspergillus fumigatus.

Perkhofer S, Trappl K, Nussbaumer W, Dierich MP, Lass-Flörl C.

J Antimicrob Chemother. 2010 Jun;65(6):1309-11. doi: 10.1093/jac/dkq111. Epub 2010 Apr 8. No abstract available.

PMID:
20378674
19.

Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection.

Ott HW, Griesmacher A, Schnapka-Koepf M, Golderer G, Sieberer A, Spannagl M, Scheibe B, Perkhofer S, Will K, Budde U.

Am J Clin Pathol. 2010 Feb;133(2):322-30. doi: 10.1309/AJCPZSBTD2BWOMVL.

PMID:
20093243
20.

In vitro susceptibility testing in fungi: a global perspective on a variety of methods.

Lass-Flörl C, Perkhofer S, Mayr A.

Mycoses. 2010 Jan;53(1):1-11. doi: 10.1111/j.1439-0507.2009.01813.x. Review.

PMID:
20078786
21.

Potential antifungal effects of human platelets against zygomycetes in vitro.

Perkhofer S, Kainzner B, Kehrel BE, Dierich MP, Nussbaumer W, Lass-Flörl C.

J Infect Dis. 2009 Oct 1;200(7):1176-9. doi: 10.1086/605607.

22.

Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.

Perkhofer S, Lass-Flörl C.

Expert Opin Investig Drugs. 2009 Sep;18(9):1393-404. doi: 10.1517/13543780903160658. Review.

PMID:
19656074
23.

In vitro activity of Isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.

Perkhofer S, Lechner V, Lass-Flörl C; European Committee on Antimicrobial Susceptibility Testing.

Antimicrob Agents Chemother. 2009 Apr;53(4):1645-7. doi: 10.1128/AAC.01530-08. Epub 2009 Jan 21.

24.

A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates.

Blum G, Perkhofer S, Grif K, Mayr A, Kropshofer G, Nachbaur D, Kafka-Ritsch R, Dierich MP, Lass-Flörl C.

Clin Microbiol Infect. 2008 Dec;14(12):1146-51. doi: 10.1111/j.1469-0691.2008.02099.x.

25.

In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing.

Lass-Flörl C, Alastruey-Izquierdo A, Cuenca-Estrella M, Perkhofer S, Rodriguez-Tudela JL.

Antimicrob Agents Chemother. 2009 Feb;53(2):794-5. doi: 10.1128/AAC.00335-08. Epub 2008 Dec 8.

26.

Human platelets attenuate Aspergillus species via granule-dependent mechanisms.

Perkhofer S, Kehrel BE, Dierich MP, Donnelly JP, Nussbaumer W, Hofmann J, von Eiff C, Lass-Flörl C.

J Infect Dis. 2008 Oct 15;198(8):1243-6. doi: 10.1086/591458.

27.

Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.

Lass-Flörl C, Mayr A, Perkhofer S, Hinterberger G, Hausdorfer J, Speth C, Fille M.

Antimicrob Agents Chemother. 2008 Oct;52(10):3637-41. doi: 10.1128/AAC.00662-08. Epub 2008 Aug 11.

28.

Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.

Arendrup MC, Perkhofer S, Howard SJ, Garcia-Effron G, Vishukumar A, Perlin D, Lass-Flörl C.

Antimicrob Agents Chemother. 2008 Oct;52(10):3504-11. doi: 10.1128/AAC.00190-08. Epub 2008 Jul 21.

29.

Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.

Perkhofer S, Locher M, Cuenca-Estrella M, Rüchel R, Würzner R, Dierich MP, Lass-Flörl C.

Antimicrob Agents Chemother. 2008 Jul;52(7):2636-8. doi: 10.1128/AAC.00492-08. Epub 2008 May 5.

30.

In vitro susceptibility-testing in Aspergillus species.

Lass-Flörl C, Perkhofer S.

Mycoses. 2008 Sep;51(5):437-46. doi: 10.1111/j.1439-0507.2008.01510.x. Epub 2008 Apr 16. Review.

PMID:
18422914
31.

Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions.

Perkhofer S, Jost D, Dierich MP, Lass-Flörl C.

Antimicrob Agents Chemother. 2008 May;52(5):1873-5. doi: 10.1128/AAC.01572-07. Epub 2008 Mar 17.

32.

Potential basis for amphotericin B resistance in Aspergillus terreus.

Blum G, Perkhofer S, Haas H, Schrettl M, Würzner R, Dierich MP, Lass-Flörl C.

Antimicrob Agents Chemother. 2008 Apr;52(4):1553-5. doi: 10.1128/AAC.01280-07. Epub 2008 Feb 11.

33.

Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein.

Vogl G, Lesiak I, Jensen DB, Perkhofer S, Eck R, Speth C, Lass-Flörl C, Zipfel PF, Blom AM, Dierich MP, Würzner R.

Mol Immunol. 2008 Mar;45(5):1485-93. Epub 2007 Oct 25.

34.

Influence of amphotericin B and amphotericin B colloidal dispersion on the functions of human phagocytes in defence against Aspergillus species.

Perkhofer S, Blum G, Speth C, Mayr A, Dierich MP, Lass-Flörl C.

Eur J Clin Microbiol Infect Dis. 2007 Jun;26(6):413-7.

PMID:
17486378
35.

In vitro determination of phagocytosis and intracellular killing of Aspergillus species by mononuclear phagocytes.

Perkhofer S, Speth C, Dierich MP, Lass-Flörl C.

Mycopathologia. 2007 Jun;163(6):303-7. Epub 2007 Apr 26.

PMID:
17458710
36.

Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro.

Perkhofer S, Niederegger H, Blum G, Burgstaller W, Ledochowski M, Dierich MP, Lass-Flörl C.

Int J Antimicrob Agents. 2007 Apr;29(4):424-9. Epub 2007 Feb 2.

37.

Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro.

Perkhofer S, Lugger H, Dierich MP, Lass-Flörl C.

Antimicrob Agents Chemother. 2007 Feb;51(2):791-3. Epub 2006 Nov 20.

Supplemental Content

Loading ...
Support Center